Serine Active Site Containing 1 (SERAC1) (C-Term) Peptide
SERAC1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5513934
Quick Overview for Serine Active Site Containing 1 (SERAC1) (C-Term) Peptide (ABIN5513934)
Target
SERAC1
(Serine Active Site Containing 1 (SERAC1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- AVRKVLATSA KILRNPFADP FSTVDIEDHE CAVWLLLRKS KSDDKTTRLE
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-SERAC1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- SERAC1 (Serine Active Site Containing 1 (SERAC1))
-
Background
-
The protein encoded by this gene is a phosphatidylglycerol remodeling protein found at the interface of mitochondria and endoplasmic reticula, where it mediates phospholipid exchange. The encoded protein plays a major role in mitochondrial function and intracellular cholesterol trafficking. Defects in this gene are a cause of 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome (MEGDEL). Two transcript variants, one protein-coding and the other non-protein coding, have been found for this gene.
Protein Size: 167 -
Gene ID
- 84947
Target
-
You are here:
